Unlock instant, AI-driven research and patent intelligence for your innovation.

Nucleic acid molecules for pseudouridylation

A nucleic acid molecule, pseudouridine technology, applied in the field of snoRNA, can solve problems such as instability

Pending Publication Date: 2020-12-01
UNIVERSITY OF ROCHESTER +1
View PDF11 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The artificial H / ACA snoRNAs described in the prior art are usually in the ~140nt range, and they consist of RNA, which makes them prone to being very unstable in vivo
Therefore, manufacturing and delivering such molecules in therapeutic settings remains a challenge

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleic acid molecules for pseudouridylation
  • Nucleic acid molecules for pseudouridylation
  • Nucleic acid molecules for pseudouridylation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0115] Example 1: Design of pseudouridylated guide oligonucleotides derived from the structure of small nucleolar RNAs (snoRNAs) for converting specific uridines to ψ in ACA19 target RNAs.

[0116] The present inventors questioned whether it is possible to induce pseudourylation using a shortened box H / ACA snoRNA. To this end, a pseudouridylated guide RNA was designed in which most of the 5′ hairpin and H-box of the full-length ACA19 snoRNA were removed ( Figure 4 ). Shortened guide RNAs and full-length snoRNAs were generated by in vitro transcription using T7 RNA polymerase. For testing in cell lysates, by using T7 RNA polymerase (in [α- 32 p]UTP) to generate short substrate RNAs for these guides by in vitro transcription or by two-part ligation. For the latter, first, the 5′ hydroxyl of a synthetic RNA oligonucleotide that is pseudouridylated at the 5′ end of the uridine terminated with [γ- 32 P] phosphate for radiolabelling. The 5' end of the radiolabeled RNA oligonuc...

Embodiment 2

[0120] Example 2: Design of psEON for conversion of specific uridines in premature stop codons of human CFTR.

[0121] It was investigated whether uridine in the premature stop codon (PTC) in the human CFTR gene could be converted to ψ. For example, the CFTR-G542X mutation was selected. The testing process was as described in Example 1.

[0122] Substrate RNA (two-part connection) is constructed similarly to Example 1, and the final target sequence is 5'-GACAAUAUAGUUCUU U GAGAAGGUGGAAUC-3' (target uridine underlined; SEQ ID NO: 2).

[0123] Figure 8 Four CFTR-G542X psEONs are shown with their introduced chemical modifications: black dots indicate the 2'-OMe modification on the ribose moiety of the nucleotide, open dots indicate the bonded PS modification between the two ribose sugars. Figure 9Results are shown for pseudouridylation using four CFTR-G542X psEONs with the corresponding guide RNA (lack of chemical modification) as a positive control and no guide RNA as a neg...

Embodiment 3

[0124] Example 3: Design of snoRNAs for conversion of specific uridines in premature stop codons in mouse Idua RNA.

[0125] investigated whether uridine in PTC in mouse Idua RNA could be converted to ψ. As an example, the Idua-W392X mutation in mouse RNA was chosen, which corresponds to the human IDUAW402X mutation known to cause Hurler Syndrome. For this, a substrate RNA was constructed similar to Example 1 (two-part ligation) with the final sequence 5'-GAUGGAGAACAACUC U AGGCAGAGGUCUCA-3' (target uridine underlined; SEQ ID NO: 3).

[0126] Figure 10 The positions of the four Idua-W392X psEONs and the introduced chemical modifications are shown: black dots indicate the 2′-OMe modification on the ribose moiety of this nucleotide, open dots indicate the bonded PS modification between the two ribose sugars. Figure 11 Results are shown for pseudouridylation using four Idua-W392X psEONs with the corresponding guide RNA (lack of chemical modification) as a positive control and...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to nucleic acid molecules for pseudouridylation of a target uridine in a target RNA in a mammalian cell, wherein the nucleic acid molecule comprises a guide region capable of forming a partially double stranded nucleic acid complex with the target RNA comprising the target uridine, wherein the partially double stranded nucleic acid complex is capable of engaging a mammalian pseudouridylation enzyme, wherein the guide region assists in positioning the target uridine in the partially double stranded nucleic acid complex for it to be converted to a pseudouridine by the mammalian pseudouridylation enzyme.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to and benefit of U.S. Provisional Patent Application No. 62 / 648,648, filed March 27, 2018; the entire contents of which are incorporated herein by reference. [0003] sequence listing [0004] This application contains a Sequence Listing, which has been filed electronically in ASCII format, and is hereby incorporated by reference in its entirety. Said ASCII copy, created on March 21, 2019, is named PQR_021WO_SL25.txt and is 32,768 bytes in size. technical field [0005] The present invention relates to the field of medicine. More specifically, the present invention relates to the field of pseudouridine, in which RNA molecules in cells are targeted by nucleic acid molecules, such as oligonucleotides, to recruit pseudouridine synthase to convert specific uridines present in the RNA sequence into pseudouridines. Uridine. More specifically, the present invention relates to oligonucleotid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/113C12N15/10A61K31/713C12N5/10
CPCC12N15/113C12N2310/20C12N2310/315C12N2310/321C12N2310/335C12Q1/68
Inventor B·克莱恩J·J·图鲁宁L·范辛特菲特P·D·M·F·A·达席尔瓦J·A·G·布代虞一涛足立大典M·D·索伊萨
Owner UNIVERSITY OF ROCHESTER